Approval · Notice of Compliance 27644 · 2022
ARIMIDEX: Notice of Compliance 27644
Issued February 21, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27644
- Date
- February 21, 2022
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARIMIDEX | Not yet assigned | — |
Medicinal ingredients
- ANASTROZOLE 1 MG per TAB